MedPath

Investigating the effects of Lavandula Tablet on the condition of headache in patients with migraine

Phase 2
Recruiting
Conditions
Migraine.
Migraine
Registration Number
IRCT20180103038199N18
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
52
Inclusion Criteria

Patients with Migraine
Age between 20 to 60

Exclusion Criteria

Suffering from chronic diseases
Suffering from diseases associated with weak immune system
Using lavender products or unknown drugs in the last three months
Abuse of drugs and substances
History of seizures and head trauma
Pregnant and lactating mothers

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in pain intensity in migraine attacks. Timepoint: Every migraine attack. Method of measurement: VAS pain questionnaire.;Change in numbers of migraine attacks. Timepoint: Every migraine attack. Method of measurement: Checklist.;Change in pain duration in each migraine attack. Timepoint: Every migraine attack. Method of measurement: Checklist.
Secondary Outcome Measures
NameTimeMethod
Changes in the impact of headache complications on quality of life. Timepoint: In every migraine attack. Method of measurement: HIT-6 questionnaire.
© Copyright 2025. All Rights Reserved by MedPath